Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 351 filings
- On EDGAR
- CIK 1822462
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 27
News 8 of 88
Prospectuses and Registrations 8 of 19
- S-8 Registration statement for an employee plan Mar 26, 2026
- 424B5 Prospectus supplement for an offering Jan 12, 2026
- 424B5 Prospectus supplement for an offering Mar 20, 2025
- S-3 Shelf registration statement Jan 24, 2025
- S-8 Registration statement for an employee plan Jan 24, 2025
- 424B5 Prospectus supplement for an offering Aug 8, 2024
- 424B5 Prospectus supplement for an offering May 20, 2024
- S-8 Registration statement for an employee plan May 6, 2024
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material May 5, 2025
- DEF 14A Proxy statement for a shareholder vote May 5, 2025
- DEFA14A Extra proxy material May 3, 2024
- DEF 14A Proxy statement for a shareholder vote May 3, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 178
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
- 4 Insider reported a trade Jun 25, 2026
Other 8 of 28
- ARS Annual report sent to shareholders Apr 30, 2026
- ARS Annual report sent to shareholders May 5, 2025
- EFFECT Notice that a registration became effective Jan 31, 2025
- CORRESP Reply to SEC staff Jan 29, 2025
- UPLOAD Comment letter from SEC staff Jan 29, 2025
- ARS Annual report sent to shareholders May 3, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- UPLOAD Comment letter from SEC staff Aug 17, 2022
Everything here comes from Foghorn Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.